Catherine Passirani Selected Research

ferrociphenol

1/2015	Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.
2/2012	Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
2/2012	Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
12/2011	Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
1/2010	Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.
9/2008	Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine Passirani Research Topics

Disease

31	Neoplasms (Cancer) 09/2023 - 06/2003
16	Glioma (Gliomas) 01/2016 - 06/2003
12	Melanoma (Melanoma, Malignant) 01/2023 - 02/2012
5	Brain Neoplasms (Brain Tumor) 11/2014 - 03/2004
4	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2008
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2015
2	Intervertebral Disc Degeneration 02/2024 - 08/2022
2	Triple Negative Breast Neoplasms 12/2020 - 09/2013
2	Gliosarcoma 02/2012 - 12/2011
1	Adenocarcinoma 10/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2022
1	Carcinoma (Carcinomatosis) 10/2022
1	Low Back Pain (Lumbago) 08/2022
1	Huntington Disease (Huntington's Disease) 03/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2015
1	Neoplasm Metastasis (Metastasis) 11/2014
1	Carcinogenesis 11/2014
1	Cardiotoxicity 11/2013
1	Macular Degeneration (Age-Related Maculopathy) 06/2012
1	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2012
1	Atrophy 10/2006
1	Wounds and Injuries (Trauma) 10/2006
1	Heart Diseases (Heart Disease) 07/2002

Drug/Important Bio-Agent (IBA)

26	NanocapsulesIBA 01/2023 - 09/2008
25	LipidsIBA 01/2023 - 09/2008
7	Small Interfering RNA (siRNA)IBA 12/2020 - 06/2012
6	ferrocifenIBA 01/2023 - 12/2017
6	ferrociphenolIBA 01/2015 - 09/2008
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 03/2011
3	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 03/2004
3	Nucleic AcidsIBA 03/2016 - 08/2008
3	poly(methylidene malonate) 2.1.2IBA 10/2006 - 06/2003
2	MicroRNAs (MicroRNA)IBA 02/2024 - 08/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 04/2012
2	ProdrugsIBA 01/2020 - 02/2012
2	SolutionsIBA 11/2013 - 06/2003
2	Tamoxifen FDA LinkGeneric 09/2013 - 09/2008
2	Ethylene Glycol (Monoethylene Glycol)IBA 12/2012 - 11/2010
2	Ganciclovir (Cytovene)FDA LinkGeneric 12/2012 - 02/2012
2	Cell-Free Nucleic AcidsIBA 12/2012 - 01/2010
2	PolymersIBA 05/2012 - 10/2006
2	MicellesIBA 05/2012 - 09/2008
2	Fluorouracil (Carac)FDA LinkGeneric 03/2004 - 06/2003
1	Thioredoxin-Disulfide ReductaseIBA 09/2023
1	Organometallic CompoundsIBA 10/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2022
1	Dichlorodiphenyldichloroethane (DDD)IBA 08/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	N-vinyl-2-pyrrolidinoneIBA 04/2021
1	imidazoleIBA 04/2021
1	GoldIBA 01/2020
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 08/2019
1	DesminIBA 03/2019
1	Peptides (Polypeptides)IBA 07/2018
1	MetalsIBA 12/2017
1	Biocompatible Materials (Biomaterials)IBA 03/2016
1	Bovine Serum AlbuminIBA 09/2014
1	Prostaglandins AIBA 05/2014
1	AsparagineIBA 12/2013
1	Docetaxel (Taxotere)FDA Link 12/2013
1	Endothelial Growth FactorsIBA 10/2013
1	LuciferasesIBA 09/2013
1	afimoxifene (hydroxytamoxifen)IBA 09/2013
1	Thymidine KinaseIBA 12/2012
1	Galactose (Galactopyranose)FDA LinkGeneric 12/2012
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 12/2012
1	Transferrin (beta 2 Transferrin)IBA 06/2012
1	Liposomes (Liposome)IBA 05/2012
1	EnzymesIBA 02/2012
1	CyclodextrinsIBA 01/2011
1	CamptothecinIBA 01/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2011
1	LigandsIBA 11/2010
1	Hormones (Hormone)IBA 09/2008
1	Drug CarriersIBA 09/2008
1	EmulsionsIBA 03/2004
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2002

Therapy/Procedure

20	Therapeutics 08/2022 - 11/2010
8	Drug Therapy (Chemotherapy) 10/2022 - 06/2003
5	Intravenous Injections 07/2018 - 03/2011
3	Microspheres (Microsphere) 10/2006 - 06/2003
2	Radiotherapy 10/2013 - 01/2010
1	Subcutaneous Injections 03/2019
1	Transplantation 03/2016
1	Intraperitoneal Injections 09/2013